135 related articles for article (PubMed ID: 29843758)
1. Preoperative assessment of ovarian tumors using a modified multivariate index assay.
Abdurrahman HA; Jawad AK; Alalalf SK
J Ovarian Res; 2018 May; 11(1):41. PubMed ID: 29843758
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer.
Longoria TC; Ueland FR; Zhang Z; Chan DW; Smith A; Fung ET; Munroe DG; Bristow RE
Am J Obstet Gynecol; 2014 Jan; 210(1):78.e1-9. PubMed ID: 24055582
[TBL] [Abstract][Full Text] [Related]
3. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay.
Goodrich ST; Bristow RE; Santoso JT; Miller RW; Smith A; Zhang Z; Ueland FR
Am J Obstet Gynecol; 2014 Jul; 211(1):65.e1-65.e11. PubMed ID: 24530816
[TBL] [Abstract][Full Text] [Related]
4. Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.
Coleman RL; Herzog TJ; Chan DW; Munroe DG; Pappas TC; Smith A; Zhang Z; Wolf J
Am J Obstet Gynecol; 2016 Jul; 215(1):82.e1-82.e11. PubMed ID: 26970494
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Ueland FR; Desimone CP; Seamon LG; Miller RA; Goodrich S; Podzielinski I; Sokoll L; Smith A; van Nagell JR; Zhang Z
Obstet Gynecol; 2011 Jun; 117(6):1289-1297. PubMed ID: 21606739
[TBL] [Abstract][Full Text] [Related]
6. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Validated Biomarker Test in Combination With a Symptom Index to Predict Ovarian Malignancy.
Urban RR; Smith A; Agnew K; Bonato V; Goff BA
Int J Gynecol Cancer; 2017 Feb; 27(2):233-238. PubMed ID: 27870706
[TBL] [Abstract][Full Text] [Related]
8. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
10. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
11. Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker.
Sánchez Vega JF; Murillo Bacilio MDR; Vintimilla Condoy AS; Palta González AM; Crespo Astudillo JA; Mora-Bravo FG
BMC Cancer; 2018 May; 18(1):587. PubMed ID: 29793429
[TBL] [Abstract][Full Text] [Related]
12. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
Li QL; Wang CJ; Qi P; Zhang YX
Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
[TBL] [Abstract][Full Text] [Related]
13. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
Czekierdowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
[TBL] [Abstract][Full Text] [Related]
14. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
Dora SK; Dandapat AB; Pande B; Hota JP
J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
[TBL] [Abstract][Full Text] [Related]
15. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum inhibin levels in patients with ovarian tumors.
El-Shalakany A; Abou-Talib Y; Shalaby HS; Sallam M
J Obstet Gynaecol Res; 2004 Apr; 30(2):155-61. PubMed ID: 15009621
[TBL] [Abstract][Full Text] [Related]
17. Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass.
Goff BA; Agnew K; Neradilek MB; Gray HJ; Liao JB; Urban RR
Gynecol Oncol; 2017 Nov; 147(2):291-295. PubMed ID: 28860006
[TBL] [Abstract][Full Text] [Related]
18. Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer.
Matsuhashi T; Takeshita T; Yamamoto A; Kawase R; Yamada T; Kurose K; Doi D; Konnai K; Onose R; Kato H
J Nippon Med Sch; 2017; 84(4):170-176. PubMed ID: 28978897
[TBL] [Abstract][Full Text] [Related]
19. Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.
Terlikowska KM; Dobrzycka B; Witkowska AM; Mackowiak-Matejczyk B; Sledziewski TK; Kinalski M; Terlikowski SJ
J Ovarian Res; 2016 Jul; 9(1):43. PubMed ID: 27436085
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer.
Muallem MZ; Parashkevova A; Almuheimid J; Richter R; Diab Y; Braicu EI; Sehouli J
Anticancer Res; 2017 Jun; 37(6):3157-3161. PubMed ID: 28551658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
